Identification of the epileptogenic lobe in neocortical epilepsy with proton MR spectroscopic imaging

Epilepsia

Volumn 45, Issue 12, 2004, Pages 1580-1589

  Mueller, Susanne G ^a,c   Laxer, Kenneth D ^b   Barakos, Jerome A ^b   Cashdollar, Nathan ^a   Flenniken, Derek L ^a   Vermathen, Peter ^a   Matson, Gerald B ^a   Weiner, Michael W ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Focus identification; Malformation; MRS; Neocortical epilepsy

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAM; EPILEPTIC FOCUS; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; WHITE MATTER;

ADOLESCENT; ADULT; ASPARTIC ACID; BRAIN MAPPING; CHOLINE; CREATINE; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOCORTEX;

EID: 10644282106     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.53003.x     Document Type: Article

References (36)

1. Engel J Jr. Approaches to localization of the epileptogenic lesion. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1987:75-95.
2. McIntosh AM, Wilson SJ, Berkovic SF. Seizure outcome after temporal lobectomy: current research practice and findings. Epilepsia 2001;42:1288-307.
3. Salanova V, Markand O, Worth R. Temporal lobe epilepsy surgery: outcome, complications and late mortality rate in 215 patients. Epilepsia 2002;43:170-4.
4. Juhász C, Chugani DC, Muszik O, et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 2001;56:1650-8.
5. Hong KS, Sang KL, Kim JY, et al. Pre-surgical evaluation and surgical outcome of 41 patients with non-lesional neocortical epilepsy. Seizure 2002;11:184-92.
6. Park SA, Lim SR, Kim GS, et al. Ictal electrocorticographic findings related with surgical outcomes in nonlesional neocortical epilepsy. Epilepsy Res 2002;48:199-206.
7. Lee SK, Kim JY, Hong KS, et al. The clinical usefulness of ictal surface EEG in neocortical epilepsy. Epilepsia 2000;41:1450-5.
8. Foldvary N, Klem G, Hammel J, et al. The localizing value of ictal EEG in focal epilepsy. Neurology 2001;57:2022-8.
9. Spencer SS, Theodore WH, Berkovic SF. Clinical applications: MRI, SPECT and PET. Magn Reson Imaging 1995;13:1119-24.
10. Grant PE, Barkovich AJ, Wald LL, et al. High-resolution surface-coil MR of cortical lesions in medically refractory epilepsy: a prospective study. AJNR Am J Neuroradiol 1997;18:291-301.
11. Kim SK, Wang KC, Kim KJ, et al. Pediatric intractable epilepsy: the role of presurgical evaluation and seizure outcome. Child Nerv Syst 2000;16:278-86.
12. Lewis PJ, Siegel A, Siegel AM, et al. Does performance image registration and subtraction in ictal brain SPECT help localize neocortical seizures? J Nucl Med 2000;41:1619-26.
13. O'Brien TJ, So EL, Mullan B, et al. Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome. Neurology 2000;55:1668-77.
14. Hwang SI, Kim JH, Park SW, et al. Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy. AJNR Am J Neuroradiol 2001;22:937-46.
15. Henry TR, Sutherling WW, Engel J Jr, et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 1991;10:174-82.
16. Richardson MP, Koepp MJ, Brooks DJ, et al. 11C-flumazenil PET in neocortical epilepsy. Neurology 1998;51:485-92.
17. Theodore WH, Gaillard WD. Positron emission tomography in neocortical epilepsies. Adv Neurol 2000;84:435-46.
18. Garcia PA, Laxer KD, van der Grond J, et al. Proton resonance spectroscopic imaging in patients with frontal lobe epilepsy. Ann Neurol 1995;37:279-81.
19. Stanley JA, Cendes F, Dubeau F, et al. Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia 1998;39:267-73.
20. Savic I, Thomas KE, Ke Y, et al. In vivo measurements of glutamine+glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy. Acta Neurol Scand 2000;102:179-88.
21. Lundbom N, Gaily E, Vuori K, et al. Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy. Epilepsia 2001;42:1507-14.
22. Tanabe JL, Amend D, Schuff N, et al. Tissue segmentation of the brain in Alzheimer disease. Am J Neuroradiol 1997;18:115-23.
23. Mueller SG, Suhy J, Laxer KD, et al. Reduced extrahippocampal NAA in mesial temporal lobe epilepsy. Epilepsia 2002;43:1210-6.
24. Schuff N, Ezekiel F, Gamst AC, et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Mag Reson Med 2001;45:899-907.
25. Damasio H. Human brain anatomy in computerized images. New York: Oxford University Press, 1995.
26. Haupt CI, Schuff N, Weiner MW, et al. Removal of lipid artifacts in 1H spectroscopic imaging by data extrapolation. Magn Reson Med 1996;35:678-87.
27. Maudsley AA, Lin E, Weiner MW. Spectroscopic imaging display and analysis. Magn Reson Imaging 1992;10:471-85.
28. Soher BJ, Young K, Govindaraju V, et al. Automated spectral analysis, III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998;40:822-31.
29. Jacobs MA, Horská A, van Zijl PCM, et al. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Mag Reson Med 2001;46:699-705.
30. Fink GR, Frackowiak RSJ, Pietrzyk U, et al. Multiple nonprimary motor areas in the human cortex. J Neurophysiol 1997;77:2164-74.
31. Vermathen P, Ende G, Laxer KD, et al. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann Neurol 1997;42:194-9.
32. Levesque MF, Nakasato N, Vinters HV, et al. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg 1991;75:364-70.
33. Miller SP, Li LM, Cendes F, et al. Medial temporal lobe neuronal damage in temporal and extratemporal lesional epilepsy. Neurology 2000;54:1465-70.
34. Li LM, Cendes F, Watson C, et al. Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology 1997;48:437-44.
35. Li LM, Cendes F, Andermann F, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999;122:799-805.
36. Guye M, Le Fur Y, Confort-Gouny S, et al. Metabolic and electrophysiological alterations in subtypes of temporal lobe epilepsy: a combined proton magnetic resonance spectroscopic imaging and depth electrodes study. Epilepsia 2002;43:1197-209.